News
Sensorion to Present at the Inner Ear Disorder Therapeutics Summit in June 2022
Regulatory News:
Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and
Valbiotis meldet bedeutenden Erfolg der klinischen Phase-II-Studie HEART: die patentgeschützte pflanzenbasierte aktive Substanz TOTUM•070 zeigt Wirksamkeit gegen Hypercholesterinämie, einen kardiovaskulären Risikofaktor
Valbiotis (FR0013254851 - ALVAL, PEA/KMU-qualifiziert), ein Forschungs- und Entwicklungsunternehmen, das sich der wissenschaftlichen Innovation zur Vorbeugung und Bekämpfung von Stoffwechsel- und
Valbiotis announces the major success of the Phase II HEART clinical study: the patented plant-based active substance TOTUM•070 proves its efficacy against hypercholesterolemia, a cardiovascular risk factor
Regulatory News:
Valbiotis (FR0013254851 - ALVAL, PEA/SME eligible), a Research and Development company committed to scientific innovation for preventing and combating metabolic diseases
Bryan Garnier & Co Initiates the Coverage of Median Technologies with a “Buy” Recommendation
Regulatory News:
Median Technologies (ALMDT) announces today the publication of an initiation report by Bryan Garnier & Co, a pan-European investment bank focusing on growth companies.
In the
DGAP-News: Abivax releases the results of its June 9, 2022 ordinary annual and extraordinary general meeting
Eutelsat Awarded ISO 14001 Certification for its Turin Teleport
Regulatory News:
Eutelsat Communications (Paris:ETL):
Eutelsat's teleport in Turin, Italy, has just been granted ISO 14001 certification, testifying to the Group's commitment to mitigating the
NANOBIOTIX: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital
Regulatory News:
Nanobiotix (Paris:NANO) (NASDAQ:NBTX)
Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.PA
Website: w
RUBIS: Minutes of the CSM of 9 June 2022: approval of all resolutions and business update
Sensorion to Present at the Gene Therapy Development and Manufacturing Conference in June 2022
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within
Poxel Announces New Solid Form Patent for PXL065 that Provides Additional Protection through 2041
POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including
ESI Group gehört dem Euronext Tech Leaders Segment an
ESI Group, Rungis, Frankreich, (ISIN Code: FR0004110310, Symbol: ESI), ein globaler Partner für Simulations- und Virtual-Prototyping-Software für die Industrie, gab heute bekannt, dass das
ESI Group Joins the Euronext Tech Leaders Segment
Regulatory News:
ESI Group, Rungis, France, (ISIN Code: FR0004110310, Symbol: ESI), a global simulation and virtual prototyping software partner for the industry, today announced that it will
Eutelsat Supporting Mexican “Internet para todos” Connectivity Programme
Regulatory News:
As the end of the school year approaches in multiple countries, including for children in Mexico across the country, Eutelsat Communications (Euronext Paris: ETL) (Paris:ETL)
Pharnext Announces Successful Debt Refinancing and New Loan Agreement
Sensorion Announces Approval in France to Initiate Proof of Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation
Regulatory News:
Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within
Thales Major Citizen Survey Predicts Warm Welcome for New European Digital ID Wallet (EDIW)
A major new survey by Thales shows that two out of three Europeans citizens are looking forward to the arrival of an EU-backed Digital ID Wallet for storing their ID card, driving licence and other
Transgene Presented Additional Phase I Data with TG4050 (myvac® platform) at ASCO 2022
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that it
Große Bürgerumfrage von Thales prognostiziert, dass neue Brieftasche für die europäische digitale Identität (EUid-Brieftasche) herzlich willkommen geheißen wird
Eine große neue Umfrage von Thales zeigt, dass zwei von drei europäischen Bürgerinnen und Bürgern sich auf die Einführung einer von der EU unterstützten Brieftasche für die digitale Identität
NANOBIOTIX: New Data Featuring NBTXR3 Plus Chemoradiation and in the Preoperative Setting Support Broad Applicability for Head and Neck Cancer and Other Solid Tumor Indications
Regulatory News:
NANOBIOTIX (Euronext : NANO –– Nasdaq: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
NANOBIOTIX Annual Shareholders’ General Meeting to Be Held on June 23, 2022
Regulatory News:
NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘Company’’), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities
Median Technologies to Present an Abstract at the 2022 ASCO Annual Meeting, June 3 – 7, 2022, McCormick Place, Chicago, IL, USA
Regulatory News:
Median Technologies (ALMDT) announced today that it will be presenting an abstract at the 2022 ASCO Annual Meeting, June 3-7, McCormick Place, Chicago, IL, USA (exhibition dates
RUBIS: Information relating to the total number of voting rights and shares as of 31/05/2022
MYHOTELMATCH accelerates growth by acquiring premium concierge group My Agency
Rémy Cointreau delivers a record year
Regulatory News:
Rémy Cointreau (Paris:RCO) posted consolidated sales of €1,312.9 million in 2021-22, up +27.3% on an organic basis1 (+29.4% compared to 2019-20). The Group reaped the full